Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Mind Medicine (MindMed) Inc MNMD

Alternate Symbol(s):  N.MMED.WS | N.MMED.WA | N.MMED.WR | N.MMED

Mind Medicine (MindMed) Inc. is a clinical-stage biopharmaceutical company, which is engaged in developing products to treat brain health disorders. It is developing a pipeline of product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways. This specifically includes pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM-120 and MM-402, the Company's product candidates. MM120, is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that it is developing for the treatment of generalized anxiety disorder (GAD). MM-120 is also being studied in a subperceptual repeat administration dosing regimen for the treatment of attention deficit hyperactivity disorder (ADHD). MM-402, also referred to as R(-)-MDMA, is the Company's form of the R-enantiomer of 3,4-methylenedioxymethampheta (MDMA), which the Company is developing for the treatment of autism spectrum disorder (ASD).


NDAQ:MNMD - Post by User

Bullboard Posts
Comment by ferdie1on Jan 14, 2011 8:56pm
282 Views
Post# 17976185

RE: Positive new results at BF - Grade What's Up?

RE: Positive new results at BF - Grade What's Up?The original 43-101 was too high, as proven by the first 9 months of production, resources stated in the report are not all mineable, I had a chance to review the drill sections (prior to infill drilling) and some of the smaller zones were not economical based upon distance from the main zones. Some orebodies require very tight drill spacing as it is difficult to follow the ore from hole to hole, as I stated previously the green carbonate zones are very tricky to follow but it can be done, overhand cut and fill is the best way to mine these areas, I was hoping to see a bit more mention of some longhole bulk attempts with the flow zones, most of these zones appeared to be dipping at 50-55 deg which could be mined by limiting the block height to reduce h/w dilution, time will tell..

be nice to see the box deposit in Sask get moving.. easy tonnes  .. easy ounces.
Bullboard Posts